Report on orphan drugs in Europe suggests changing pharma incentives
“The regulations have not adequately managed to support development in areas where the need for medicines is greatest,” a European Commission report finds.
“The regulations have not adequately managed to support development in areas where the need for medicines is greatest,” a European Commission report finds.
Financial strain is created by inequitable health financing structures that overpay private academic medical centers at the expense of safety net hospitals.
A controversial provision of a federal law designed to speed copycat drugs to market and foster competition saved Medicare Part D nearly $15 billion from
“By filing bogus patent listings, pharma companies block competition and inflate the cost of prescription drugs,” said FTC Chair Lina Khan.
As sales slump, the prescription digital therapeutics maker lays off 46% of workforce, and will “evaluate potential strategic alternatives.”
Advocates of a federal ban on menthol cigarettes have spent years trying everything to sway policymakers — now, it seems, they may just have to…
Eli Lilly raised its full-year guidance while it reported strong first-quarter sales of Zepbound, its obesity drug.
In a challenge to the pharmaceutical industry, Doctors Without Borders has revealed the detailed costs of a study it ran for a tuberculosis treatment regimen.
A New Jersey district judge ruled that the Biden administration’s Medicare drug price negotiation program is constitutional
The pharmaceutical industry saw its image slip last year among patient advocacy groups, according to a new survey.
A tentative settlement has been reached in a long-running shareholder lawsuit that accused health care activist investor Alex Denner of insider trading.